Kornitzer Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Kornitzer Capital Management’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.38M	Buy	2,211 +137	+7%	+$93.3K	0.03%	376
2026 Q1	$1.6M	Buy	2,074 +183	+10%	+$140K	0.03%	332
2025 Q4	$1.46M	Buy	+1,891	New	+$1.28M	0.03%	351
2025 Q1	–	Sell	-842	Closed	-$600K	–	480
2024 Q4	$600K	Buy	+842	New	+$707K	0.01%	417

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Kornitzer Capital Management's REGN Position: Q2 2026 in Review

Kornitzer Capital Management increased its Regeneron Pharmaceuticals (REGN) stake by 6.6% in Q2 2026, buying an estimated $93.3K and bringing the position to 2,211 shares worth $1.38M. The position accounts for 0.03% of the portfolio, ranked #376.

Kornitzer Capital Management first reported a position in REGN in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.6M in Q1 2026. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Kornitzer Capital Management held 2,211 shares of Regeneron Pharmaceuticals worth $1.38M as of Q2 2026.
Kornitzer Capital Management bought 137 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $93.3K.
Regeneron Pharmaceuticals made up 0.03% of Kornitzer Capital Management's portfolio in Q2 2026, its #376 holding.
Kornitzer Capital Management first reported a position in Regeneron Pharmaceuticals in Q4 2024 and has held it in 4 quarters since.
Kornitzer Capital Management's Regeneron Pharmaceuticals position peaked at $1.6M in Q1 2026.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Kornitzer Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.